Port Townsend, Wash.-based Jefferson Healthcare has opened a retail pharmacy that will dispense specialty drugs, offer home-delivery prescriptions and stock over-the-counter drugs and medical supplies, according to the Port Townsend Leader.
Pharmacy
PillPack, which was acquired by Amazon last year, is fighting with industry heavyweights CVS and Walgreens over patient prescription transfers, according to CNBC.
Walgreens plans to close 200 stores in the U.S., decreasing its real estate footprint by about 3 percent, according to CNBC.
The FDA said Novartis used data it knew was inaccurate in its application for its $2.1 million gene therapy Zolgensma, and the agency is threatening to take criminal action against the drugmaker.
Brand-name drugmakers are increasingly making generic versions of their own drugs, a strategy that keeps drug costs high and stifles competition, critics of the practice told Kaiser Health News.
Despite an ongoing Ebola outbreak in the Democratic Republic of Congo, GlaxoSmithKline is giving up efforts to develop three vaccines to combat the virus. It will transfer rights to its work to the Sabin Vaccine Institute in the U.S.
The Pentagon considers the increasing use of Chinese-made active ingredients in drugs taken by U.S. patients a national security risk, especially as trade tensions between the U.S. and China escalate, Bloomberg reports.
Including inpatient and outpatient environments, hospitals and health systems can expect a 4.57 percent increase in pharmaceutical spending next year, according to Vizient's July 2019 drug price forecast.
Network Health, a health insurer with 120,000 members in Wisconsin, will stop using CVS Caremark as its pharmacy benefit manager Jan. 1, 2020.
OxyContin maker Purdue Pharma plans to close its manufacturing plant in Durham, N.C., by the end of the year, according to the Stamford Advocate.